DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /JAK/STAT SignalingJAK/STAT Signaling
  5. /EGFREGFR
  6. /RezivertinibRezivertinib
Chemical structure of CAS 1835667-12-3

Rezivertinib

In Stock•Starting at $97 for 5 mg•Purity ≥ 99%
CAS No.1835667-12-3
MDL No.N/A
MFC27H30N6O3
MW486.60
InChI KeyBPMZUKYFIDPLEA-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg99%$97In Stock
10 mg99%$157In Stock
25 mg99%$307In Stock
50 mg99%$482In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1835667-12-3
Product NameRezivertinib

Associated Conditions

non-small cell lung carcinoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

New drugs approved by the NMPA in 2024: Synthesis and clinical applications.

European journal of medicinal chemistry • Vol. 291 • 2025
PMID: 40262297DOI: 10.1016/j.ejmech.2025.117643

Documentation

Similar Products

  • Osimertinib

    CAS No.1421373-65-0

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact